Jim Wilson Praises iECURE's Milestone in Gene Therapy with ECUR-506 for OTCD Dr. Jim Wilson, a gene therapy innovator, shares insights on iECURE's promising results for ECUR-506 in treating Ornithine Transcarbamylase Deficiency, marking a key milestone in biotechnology.

Jim Wilson Praises iECURE's Milestone in Gene Therapy with ECUR-506 for OTCD #USA #Philadelphia #GEMMA_Biotherapeutics #iECURE #OTCD

GEMMABio Welcomes Dr. May Orfali as New Chief Medical Officer, Enhancing Clinical Leadership GEMMABio announces the appointment of Dr. May Orfali as Chief Medical Officer, bringing extensive clinical development expertise to the team.

GEMMABio Welcomes Dr. May Orfali as New Chief Medical Officer, Enhancing Clinical Leadership #United_States #Philadelphia #gene_therapy #GEMMA_Biotherapeutics #Dr._May_Orfali